X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-11-05 | ATXI | Kranzler Jay D | Dir | S - Sale | $2.24 | -61 | 559 | -10% | -$137 | ||||||
M | 2024-09-27 | ATXI | Kranzler Jay D | Dir | P - Purchase | $2.50 | +500 | 620 | +417% | +$1,250 | |||||
2023-12-11 | ATXI | Davidow Robert L | 10% | S - Sale | $0.14 | -617,000 | 1,219,800 | -34% | -$86,560 | ||||||
2023-09-08 | ATXI | Rosenwald Lindsay A Md | Dir | P - Purchase | $0.72 | +348,675 | 354,318 | >999% | +$251,046 | ||||||
2023-09-08 | ATXI | Fortress Biotech, Inc. | 10% | P - Purchase | $0.72 | +418,410 | 1,032,390 | +68% | +$301,255 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |